DOKTERS OKUYAN-YOLOGLU
0830.054.437 · rovalta.com · 27/09/2026
DOKTERS OKUYAN-YOLOGLU
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODOKTERS OKUYAN-YOLOGLU is a Private limited company incorporated in 2010. Its main activity is: General medical practice activities. Its registered office is in Genk.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0830.054.437
- Incorporation
- 30/09/2010
- Legal form
- Private limited company
- Registered office
- Onderwijslaan 23 A
3600 Genk · FlandreSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 597 k € | +15.0% | 519,3 k € | +8.0% | 480,7 k € | +32.8% | 361,9 k € | +47.4% | 245,5 k € |
| EBITDA | 544,6 k € | +12.0% | 486,2 k € | +8.4% | 448,6 k € | +37.7% | 325,8 k € | +36.5% | 238,6 k € |
| Operating result | 505,7 k € | +13.6% | 445,2 k € | +13.0% | 393,9 k € | +48.0% | 266,2 k € | +63.6% | 162,7 k € |
| Net result | 312,7 k € | +13.9% | 274,6 k € | +7.9% | 254,5 k € | +62.4% | 156,7 k € | +60.9% | 97,4 k € |
| Balance sheet | |||||||||
| Equity | 1,1 M € | +23.8% | 920,7 k € | +15.4% | 798,1 k € | +36.6% | 584,1 k € | +4.1% | 561 k € |
| Total assets | 1,7 M € | +2.1% | 1,7 M € | +16.0% | 1,5 M € | +20.4% | 1,2 M € | -2.2% | 1,2 M € |
| Cash | 518,3 k € | +81.9% | 285 k € | -29.0% | 401,5 k € | +65.2% | 243 k € | +137% | 102,7 k € |
| Debts | 595,6 k € | -23.6% | 779,9 k € | +16.9% | 667,4 k € | +5.4% | 632,9 k € | -7.4% | 683,2 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20242 active · 4 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/09/2025 | 04/10/2024 | 25/08/2023 | 18/08/2022 | 29/09/2021 | 21/12/2020 |
| General meeting | 27/06/2025 | 28/06/2024 | 30/06/2023 | 24/06/2022 | 25/06/2021 | 26/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 27/06/2025 | 23/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 28/06/2024 | 04/10/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/06/2023 | 25/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 24/06/2022 | 18/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 25/06/2021 | 29/09/2021 | Dutch | |
| Micro model | 31/12/2019 | 26/06/2020 | 21/12/2020 | Dutch | |
| Micro model | 31/12/2018 | 19/11/2019 | 06/02/2020 | Dutch | |
| Micro model | 31/12/2017 | 20/03/2019 | 01/07/2019 | Dutch | |
| Micro model | 31/12/2016 | 19/12/2017 | 07/02/2018 | Dutch | |
| Abridged model | 31/12/2015 | 03/10/2016 | 08/11/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/06/2015 | 27/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 21/11/2014 | 24/11/2014 | Dutch | |
| Abridged model | 31/12/2012 | 29/10/2013 | 19/11/2013 | Dutch | |
| Abridged model | 31/12/2011 | 18/12/2012 | 08/01/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20242 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024312,7 k €↑
- 2023Annual accounts 2023274,6 k €↑
- 2022Annual accounts 2022254,5 k €↑
- 2021Annual accounts 2021156,7 k €↑
- 2020Annual accounts 202097,4 k €↑
- 2019Annual accounts 201993,4 k €↓
- 2018Annual accounts 2018152,1 k €↑
- 2017Annual accounts 201740,5 k €↓
- 2016Annual accounts 2016103,5 k €↑
- 2015Annual accounts 201530,1 k €↑
- 2014Annual accounts 201423,6 k €↑
- 2013Annual accounts 201314,1 k €↑
- 2012Annual accounts 201212,5 k €↑
- 2011Annual accounts 2011-12,3 k €
- 30/09/2010IncorporationPrivate limited company